A positive step forward, but more needed to maximize cost benefits of new-generation cancer therapies

被引：6
作者：
Haines, Ian E. [1 ]
机构：
[1] Monash Univ, Dept Med, Melbourne Oncol Grp, Melbourne, Vic 3004, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 25期
关键词：
D O I：
10.1200/JCO.2007.12.8421
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E31 / E32
页数：2
相关论文
共 30 条
[11]   Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer [J].
Joensuu, H ;
Kellokumpu-Lehtinen, P ;
Bono, P ;
Alanko, T ;
Kataja, V ;
Asola, R ;
Utriainen, T ;
Kokko, R ;
Hemminki, A ;
Tarkkanen, M ;
Turpeenniemi-Hujanen, T ;
Jyrkkiö, S ;
Flander, M ;
Helle, L ;
Ingalsuo, S ;
Johansson, K ;
Jääskeläinen, A ;
Pajunen, M ;
Rauhala, M ;
Kaleva-Kerola, J ;
Salminen, T ;
Leinonen, M ;
Elomaa, I ;
Isola, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08) :809-820
[12]   Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer [J].
Johnson, DH ;
Fehrenbacher, L ;
Novotny, WF ;
Herbst, RS ;
Nemunaitis, JJ ;
Jablons, DM ;
Langer, CJ ;
DeVore, RF ;
Gaudreault, J ;
Damico, LA ;
Holmgren, E ;
Kabbinavar, F .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2184-2191
[13]  
Johnson DH, 2001, P AN M AM SOC CLIN, V20, p315a
[14]   Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU) leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer [J].
Kabbinavar, F ;
Hurwitz, HI ;
Fehrenbacher, L ;
Meropol, NJ ;
Novotny, WF ;
Lieberman, G ;
Griffing, S ;
Bergsland, E .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :60-65
[15]  
KABBINAVAR FF, 2001, P AN M AM SOC CLIN, V20, P277
[16]  
Krugman, 2007, NEW YORK TIMES 0514
[17]   IDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma [J].
Maloney, DG ;
GrilloLopez, AJ ;
Bodkin, DJ ;
White, CA ;
Liles, TM ;
Royston, I ;
Varns, C ;
Rosenberg, J ;
Levy, R .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (10) :3266-3274
[18]   Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: Pharmacologic and long-term safety data [J].
Margolin, K ;
Gordon, MS ;
Holmgren, E ;
Gaudreault, J ;
Novotny, W ;
Fyfe, G ;
Adelman, D ;
Stalter, S ;
Breed, J .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) :851-856
[19]  
MEIER B, 2007, NEW YORK TIMES 0323
[20]  
Pear Robert, 2007, NEW YORK TIMES 0510
123